Tris Pharma

About:

Tris Pharma is a pharmaceuticals company providing specialty generic products.

Website: http://trispharma.com

Top Investors: Deerfield, National Institute on Drug Abuse (NIDA)

Description:

Tris Pharma, Inc. is focuses on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.

Total Funding Amount:

$142M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Monmouth Junction, New Jersey, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)trispharma.com

Founders:

Ketan Mehta

Number of Employees:

251-500

Last Funding Date:

2023-08-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai